R. B. Schleicher

Clinical studies of hip: An oral heme-iron product

P. Seligman, Gary M Moore, R. B. Schleicher, 2000 .

Treatment with gallium nitrate: Evidence for interference with iron metabolism in vivo

P. Seligman, R. B. Schleicher, P. Moran, 1992, American journal of hematology.

Effects of agents that inhibit cellular iron incorporation on bladder cancer cell proliferation.

J. Domenico, E. Gelfand, P. Seligman, 1993, Blood.

Transferrin-independent iron uptake supports B lymphocyte growth.

E. Gelfand, P. Seligman, R. B. Schleicher, 1991, Blood.

Isolation and characterization of the transferrin receptor from human placenta.

R. Allen, P. Seligman, R. B. Schleicher, 1979, The Journal of biological chemistry.

Expression of Vascular Endothelial Growth Factor and Proliferation Marker MIB1 Are Influenced by Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Meenakshi Singh, C. Finlayson, P. Seligman, 2005, Applied immunohistochemistry & molecular morphology : AIMM.

Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients.

A. Nissenson, J. Berns, P. Seligman, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparison of methods used to measure serum iron in the presence of iron gluconate or iron dextran.

P. Seligman, R. B. Schleicher, Paul A. Seligman, 1999, Clinical chemistry.

Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.

J Lucas, E. Gelfand, N. Terada, 1993, Cancer research.